A Phase III, Randomized, Open, Parallel-controlled, Multi-center Study to Compare the Efficacy and Safety of Tacrolimus Capsules and Cyclophosphamide Injection in Treatment of Lupus Nephritis
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 13 Apr 2018
At a glance
- Drugs Tacrolimus (Primary) ; Cyclophosphamide; Prednisone
- Indications Lupus nephritis
- Focus Therapeutic Use
- Sponsors Astellas Pharma
- 09 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 13 Aug 2017 Planned End Date changed from 30 Jun 2018 to 1 Jun 2018.
- 13 Aug 2017 Planned primary completion date changed from 30 Jun 2018 to 1 Jun 2018.